Lomefloxacin
Especificaciones
98079-51-7Número CAS
619-317-6Número CE
1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acidNombre IUPAC
C17H19F2N3O3Fórmula química
351.35 g/molPeso molecular
lomefloxacin; 98079-51-7; Lomefloxacine; Lomefloxacino; Lomefloxacinum; LFLX; 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; SC-47111A; L6BR2WJD8V; 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; 1,4-Dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; CHEBI:116278; (+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; DTXSID4040680; Logiflox; Okacin; SC-4711; lomefloxacina; lomenfloxacin; 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; RefChem:153984; 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-, monohydrochloride; DTXCID2020680; J01MA07; S01AE04; Lomefloxacine [French]; Lomefloxacino [Spanish]; Lomefloxacinum [Latin]; DM 10 (bactericide); DM-10; 1-ethyl-6-fluoranyl-8-fluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; Lomefloxacin (USAN); LOMEFLOXACIN [USAN]; 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid; SC 47111A; 1-ethyl-6,8-difluoro-7-(3-methylpiperazinyl)-4-oxohydroquinoline-3-carboxylic acid; 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-; CCRIS 6305; Maxaquin (hydrochloride); UNII-L6BR2WJD8V; NY-198 (hydrochloride); BRN 4210041; SC-47111B (mesylate); SC-47111 (hydrochloride); Lomefloxacin [USAN:INN:BAN]; C17H19F2N3O3; Spectrum_001431; Prestwick0_000238; Prestwick1_000238; Prestwick2_000238; Prestwick3_000238; Spectrum2_000696; Spectrum3_001494; Spectrum4_000158; Spectrum5_001246; LOMEFLOXACIN [MI]; LOMEFLOXACIN [INN]; CHEMBL561; Epitope ID:119067; LOMEFLOXACIN [VANDF]; Lopac0_000678; SCHEMBL34609; BSPBio_000315; BSPBio_003107; KBioGR_000636; KBioSS_001911; DivK1c_000365; LOMEFLOXACIN [WHO-DD]; SPBio_000851; SPBio_002236; BPBio1_000347; orb1308596; SCHEMBL29388501; GTPL12407; HY-B0455A; KBio1_000365; KBio2_001911; KBio2_004479; KBio2_007047; KBio3_002607; NINDS_000365; HMS2090O16; HMS5084D10; RKL10067; BDBM50417952; EBC-26691; s5491; SBB012581; AKOS015964770; CCG-204764; DB00978; KS-5014; SDCCGSBI-0050657.P004; 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxoquinoline-3-carboxylic acid; IDI1_000365; SMP1_000287; NCGC00015603-02; NCGC00015603-03; NCGC00015603-04; NCGC00015603-05; NCGC00015603-07; NCGC00015603-16; NCGC00162221-01; NCGC00178293-01; NCGC00178293-02; 3-Quinolinecarboxylic acid, 1,4-dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-; 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-, (+-)-; FL170160; ST072201; SBI-0050657.P003; Lomefloxacin 1000 microg/mL in Acetonitrile; NS00007577; C07078; D02318; G85922; AB00053622-04; AB00053622-05; AB00053622_06; AB00053622_07; EN300-18553898; F866703; Q203618; BRD-A75850590-003-05-6; BRD-A75850590-003-06-4; BRD-A75850590-003-09-8; BRD-A75850590-213-01-0; (+/-)-1-ETHYL-6,8-DIFLUORO-1,4-DIHYDRO-7-(3-METHYL-1-PIPERAZINYL)-4-; (+/-)-1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo- (+/-); 3-QUINOLINECARBOXYLIC ACID, 1-ETHYL-6,8-DIFLUORO-1,4-DIHYDRO-7-(3-METHYL-1-PIPERAZINYL)-4-OXO-, (+/-)-Sinónimos
